Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Histone deacetylase (HDAC) inhibitors show promise in cancer treatment by inducing growth arrest and cell death.
• Suberoylanilide hydroxamic acid (SAHA) is an HDAC inhibitor with demonstrated antitumor activity in clinical trials.
• The precise mechanisms by which HDAC inhibitors induce cancer cell death are not fully understood.

Purpose of the Study:

• To investigate the effects of SAHA on cell cycle progression and cell fate in human cancer cell lines.
• To determine if SAHA induces polyploidy and senescence in transformed cells.
• To explore the role of p21WAF1 and p53 genes in SAHA-mediated cellular responses.

Main Methods:

• Treatment of human colon and breast cancer cell lines (HCT116, MCF-7, MDA-MB-231, MBA-MD-468) and normal fibroblasts with SAHA.
• Analysis of polyploidy induction using cell-based assays.
• Assessment of proliferation capacity and senescence markers in SAHA-treated cells.
• Comparison of SAHA effects in wild-type and p53/p21-deficient HCT116 cells.

Main Results:

• SAHA treatment induced polyploidy in human colon and breast cancer cell lines, but not in normal fibroblasts.
• Polyploid cells exhibited loss of proliferative capacity and entered senescence.
• SAHA-induced polyploidy was more pronounced in HCT116 cells lacking functional p21WAF1 or p53 genes.
• Senescence development was consistent across SAHA-treated colon cancer cell lines.

Conclusions:

• HDAC inhibition by SAHA can exert antitumor effects through the induction of polyploidy and subsequent senescence.
• Transformed cells with nonfunctional p21WAF1 or p53 genes are more susceptible to SAHA-induced polyploidy.
• These findings highlight a potential therapeutic strategy targeting cancer cells with specific genetic alterations.